Advertisement
Journal Home
Search for

Volume 62, Issue 1, Pages 139-144 (October 2008)


View previous. 20 of 20

Predictors of talc pleurodesis outcome in patients with malignant pleural effusions

Huseyin YildirimaCorresponding Author Informationemail address, Muzaffer Metintasa, Güntülü Aka, Selma Metintasb, Sinan Erginela

Received 17 December 2007; received in revised form 18 February 2008; accepted 24 February 2008. published online 10 April 2008.

Summary 

Objective

Chemical pleurodesis is an accepted palliative therapy for patients with recurrent, symptomatic, malignant pleural effusions (MPE). The purpose of the study was to determine the factors that have an effect on successful pleurodesis for MPE.

Patients and interventions

Eighty-four consecutive patients with biopsy-proven malignant pleural disease and recurrent, symptomatic MPE were eligible to participate in this study. Five grams of talc mixed in 150ml of normal saline were administered via tube thoracostomy or small-bore catheters after complete drainage of the pleural effusion.

Results

Seven patients did not return for their 30-day follow-up visit and were excluded from further analysis. Successful pleurodesis was achieved in 63 of 77 eligible patients (81.8%) with MPE. In the univariate analysis, female gender, Karnofsky performance status, pleural fluid pH, cholesterol, and adenosine deaminase level showed a significant association with the probability of success. Multivariate logistic regression analysis showed that pleural fluid pH and ADA levels were independent predictors of talc pleurodesis outcome.

Conclusion

Our results show that pleurodesis using talc as the sclerosing agent is a simple and acceptable procedure with high efficacy for controlling MPE, especially when used in appropriate patients.

a Osmangazi University, Medical Faculty, Department of Chest Disease, 26480 Meselik, Eskisehir, Turkey

b Osmangazi University, Medical Faculty, Department of Public Health, Eskisehir, Turkey

Corresponding Author InformationCorresponding author. Tel.: +90 222 239 29 79x3050; fax: +90 222 239 47 14.

 This study has been presented as a thematic poster at the 14th Annual Congress of European Respiratory Society.

PII: S0169-5002(08)00105-0

doi:10.1016/j.lungcan.2008.02.017


View previous. 20 of 20